Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Embecta Corp. (EMBC)

Embecta completes Owen Mumford acquisition for £100 million upfront

Neutral Impact 4 of 5 m&a Written later

Embecta Corp. completed its acquisition of Owen Mumford Holdings Limited, a privately held UK maker of medical devices and drug-delivery technologies, on May 15, 2026. The company says the deal accelerates its shift into a broad-based medical supplies business and adds the Aidaptus next-generation auto-injector platform. The filing does not disclose Owen Mumford's financial results, and the required financial statements and pro forma information will be filed later by amendment.

Key points

  • Upfront cash payment of £100 million at closing, subject to customary adjustments including closing net cash.
  • Up to an additional £50 million payable on certain commercial milestones for Aidaptus sales through June 30, 2029.
  • Transaction completed May 15, 2026 under a Purchase Agreement dated March 19, 2026, with sellers including Mark Owen and Adam Mumford.
  • Financial statements and pro forma information to be filed by amendment within 71 calendar days of the Item 2.01 filing deadline.

The filing

CompanyEmbecta Corp. (EMBC)
Form8-K, current report
Filed with the SECMay 15, 2026, 9:15 AM ET
Accession number0000947871-26-000546

Items reported: 2.01 Acquisition or Disposition Completed7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.